Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Canoo Inc.HCACU · Entity 85818 | Director | February 28, 2019 | February 28, 2019 |
| Chemours CoCC · Entity 4420 | Director | April 27, 2022 | April 29, 2022 |
| NRC GROUP HOLDINGS CORP.HCAC.U · Entity 154032 | Director | June 22, 2017 | June 22, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Canoo Inc.
Report date February 28, 2019 · Filed February 28, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnote | Not disclosed |
Reported balance
Holding disclosure · report date 2019-02-28 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: As described in the registrant's registration statement on Form S-1 (File No. 333-229608) under the heading "Description of Securities-Founder Shares," the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the registrant's initial business combination on a one-for-one basis, subject to certain adjustments described therein and have no expiration date. F2: The reporting person also has pecuniary interests in shares of Class B common stock through his membership interest in Hennessy Capital Partners IV LLC, over which the reporting person does not have voting or dispositive control. F3: The reporting person holds these securities as trustee of The Bradley J. Bell Revocable Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: As described in the registrant's registration statement on Form S-1 (File No. 333-229608) under the heading "Description of Securities-Founder Shares," the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the registrant's initial business combination on a one-for-one basis, subject to certain adjustments described therein and have no expiration date.
F2: The reporting person also has pecuniary interests in shares of Class B common stock through his membership interest in Hennessy Capital Partners IV LLC, over which the reporting person does not have voting or dispositive control.
F3: The reporting person holds these securities as trustee of The Bradley J. Bell Revocable Trust.
Chemours Co
Report date April 27, 2022 · Filed April 29, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 60,604.835 |
Reported balance
After 2022-04-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-04-27 · Grant · Acquired 4,442 · Balance 60,604.835 F1: Includes directly owned shares, stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 20,400 |
Reported balance
Holding disclosure · report date 2022-04-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 20,400 |
| Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,421.5233 |
Reported balance
Holding disclosure · report date 2022-04-27 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 9,421.5233 F2: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3: Payable upon separation from service. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes directly owned shares, stock units and dividend equivalent units.
F2: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock.
F3: Payable upon separation from service.
NRC GROUP HOLDINGS CORP.
Report date June 22, 2017 · Filed June 22, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 75,000 |
Reported balance
Holding disclosure · report date 2017-06-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 75,000 F1: The reporting person also has pecuniary interests in shares of common stock through his membership interest in Hennessy Capital Partners III LLC, over which the reporting person does not have voting or dispositive control. F2: The reporting person holds these securities as trustee of The Bradley J. Bell Revocable Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person also has pecuniary interests in shares of common stock through his membership interest in Hennessy Capital Partners III LLC, over which the reporting person does not have voting or dispositive control.
F2: The reporting person holds these securities as trustee of The Bradley J. Bell Revocable Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 27, 2022 Filed Apr 29, 2022 11:37 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 4,442 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-22-000031 · primary_doc.xml · nonDerivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,604.835 F1 · balance_after: Includes directly owned shares, stock units and dividend equivalent units. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 16:35 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 4,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-21-000029 · primary_doc.xml · nonDerivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,527.124 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 20:24 UTC | Chemours Co CC · Entity 4420 | GrantStock Units · Derivative | 605.0827 | $24.79 | $15,000.00 |
DisclosureSEC source: 0001627223-21-000002 · primary_doc.xml · derivative · entry 3 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,046.4332 Underlying: Common Stock · 605.0827 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable in installments upon separation from service. F3 · derivative.expiration_date: Payable in installments upon separation from service. F4 · balance_after: This total has been adjusted to reflect the correct number of derivative securities beneficially owned due to a clerical error that overreported the total derivative securities in previous filings. With respect to the Form 4 filing on 04-30-2020, Table II, Box 9 should have been 6475.5096. With respect to the Form 4 filing on 07-02-2020, Table II, Box 9 should have been 7558.0357. With respect to the Form 4 filing on 10-02-2020, Table II, Box 9 should have been 8364.1052. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 16:51 UTC | Chemours Co CC · Entity 4420 | GrantStock Units · Derivative | 717.3601 | $20.91 | $15,000.00 |
DisclosureSEC source: 0001627223-20-000041 · primary_doc.xml · derivative · entry 3 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,306.5555 Underlying: Common Stock · 717.3601 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable in installments upon separation from service. F3 · derivative.expiration_date: Payable in installments upon separation from service. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:28 UTC | Chemours Co CC · Entity 4420 | GrantStock Units · Derivative | 977.1987 | $15.35 | $15,000.00 |
DisclosureSEC source: 0001627223-20-000038 · primary_doc.xml · derivative · entry 3 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,589.1954 Underlying: Common Stock · 977.1987 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable in installments upon separation from service. F3 · derivative.expiration_date: Payable in installments upon separation from service. Read SEC document |
| April 28, 2020 Filed Apr 30, 2020 20:37 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 12,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000029 · primary_doc.xml · nonDerivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,906 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 21:51 UTC | Chemours Co CC · Entity 4420 | GrantStock Units · Derivative | 1,691 | $8.87 | $14,999.17 |
DisclosureSEC source: 0001627223-20-000026 · primary_doc.xml · derivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,348 Underlying: Common Stock · 1,691 shares Expires not disclosed F1 · derivative.exercise_price: Units are credited under the Chemours compensation plan for directors and convert one-for-one to Chemours common stock. F2 · derivative.exercise_date: Payable in installments upon separation from service. F2 · derivative.expiration_date: Payable in installments upon separation from service. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 20:20 UTC | Chemours Co CC · Entity 4420 | GrantStock Units · Derivative | 1,326 | $18.09 | $23,987.34 |
DisclosureSEC source: 0001627223-20-000002 · primary_doc.xml · derivative · entry 3 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,657 Underlying: Common Stock · 1,326 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable in installments upon separation from service. F3 · derivative.expiration_date: Payable in installments upon separation from service. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:39 UTC | Chemours Co CC · Entity 4420 | GrantStock Units · Derivative | 1,606.4257 | $14.94 | $24,000.00 |
DisclosureSEC source: 0001627223-19-000050 · primary_doc.xml · derivative · entry 3 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,283.2438 Underlying: Common Stock · 1,606.4257 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable in installments upon separation from service. F3 · derivative.expiration_date: Payable in installments upon separation from service. Read SEC document |
| August 05, 2019 Filed Aug 6, 2019 21:06 UTC | Chemours Co CC · Entity 4420 | PurchaseCommon Stock | 5,000 | $14.67 | $73,350.00 |
DisclosureSEC source: 0001627223-19-000044 · primary_doc.xml · nonDerivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 20,400 Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 21:45 UTC | Chemours Co CC · Entity 4420 | GrantStock Units · Derivative | 1,000 | $24.00 | $24,000.00 |
DisclosureSEC source: 0001627223-19-000041 · primary_doc.xml · derivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,652 Underlying: Common Stock · 1,000 shares Expires not disclosed F1 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F2 · derivative.exercise_date: Payable upon separation from service. F2 · derivative.expiration_date: Payable upon separation from service. Read SEC document |
| May 16, 2019 Filed May 20, 2019 18:29 UTC | Chemours Co CC · Entity 4420 | PurchaseCommon Stock | 5,000 | $24.06 | $120,300.00 |
DisclosureSEC source: 0001627223-19-000030 · primary_doc.xml · nonDerivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 15,400 Read SEC document |
| May 01, 2019 Filed May 3, 2019 15:40 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 4,165 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-19-000024 · primary_doc.xml · nonDerivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,839 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| March 29, 2019 Filed May 3, 2019 15:40 UTC | Chemours Co CC · Entity 4420 | GrantStock Units · Derivative | 645.8557 | $37.16 | $24,000.00 |
DisclosureSEC source: 0001627223-19-000024 · primary_doc.xml · derivative · entry 2 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 645.8557 Underlying: Common Stock · 645.8557 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable upon separation from service in five annual installments. F3 · derivative.expiration_date: Payable upon separation from service in five annual installments. Read SEC document |
| May 02, 2018 Filed May 4, 2018 21:13 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 2,683 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-18-000026 · primary_doc.xml · nonDerivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,963 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 20:31 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 3,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-17-000032 · primary_doc.xml · nonDerivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,142 F1 · shares: Restricted stock units (RSUs) that vest upon termination of service. F2 · balance_after: Includes unvested RSUs and dividend equivalent units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.